Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia R Wigle

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
American Health & Drug Benefits|November 23, 2018
Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015Xiaomeng Yue, Jeff Jianfei Guo, Patricia R Wigle
Primary Care Companion to the Journal of Clinical Psychiatry|January 26, 2010
Case report of valproate-induced hypothermia in a patient with schizoaffective disorderMatthew R Tubb, Christopher C White, Patricia R Wigle
Intractable & Rare Diseases Research|September 4, 2025
Literature analysis and implication of biologic therapy for children with non-systemic juvenile idiopathic arthritis in real-world settingsAlbert Fung, Xiaomeng Yue, Patricia R Wigle, et al.
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Comparison of potentially hepatotoxic drugs among major US drug compendiaJeff J Guo, Patricia R Wigle, Kangsan Lammers, et al.
Intractable & Rare Diseases Research|December 8, 2021
Off-label medication use in rare pediatric diseases in the United StatesAlbert Fung, Xiaomeng Yue, Patricia R Wigle, et al.
Research in Social & Administrative Pharmacy : RSAP|January 29, 2011
Evaluation of online consumer medication informationKarissa Y Kim, Anne Metzger, Patricia R Wigle, et al.
International Journal of Cardiology|October 28, 2022
The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year PeriodRawan O Almadfaa, Patricia R Wigle, Ana L Hincapie, et al.
Journal of Managed Care Pharmacy : JMCP|November 12, 2010
ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008Boyang Bian, Christina M L Kelton, Jeff J Guo, et al.
The Journal of Family Practice|January 16, 2010
Answers to your questions about SSRIsChristopher White, Patricia R Wigle, Elizabeth Eichel, et al.
Current Drug Safety|March 10, 2010
Evaluating safety of long-acting beta agonists (LABAs) in patients with asthmaBoyang Bian, Christina M L Kelton, Patricia R Wigle, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
American Health & Drug Benefits|November 23, 2018
Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015Xiaomeng Yue, Jeff Jianfei Guo, Patricia R Wigle
Primary Care Companion to the Journal of Clinical Psychiatry|January 26, 2010
Case report of valproate-induced hypothermia in a patient with schizoaffective disorderMatthew R Tubb, Christopher C White, Patricia R Wigle
Intractable & Rare Diseases Research|September 4, 2025
Literature analysis and implication of biologic therapy for children with non-systemic juvenile idiopathic arthritis in real-world settingsAlbert Fung, Xiaomeng Yue, Patricia R Wigle, et al.
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Comparison of potentially hepatotoxic drugs among major US drug compendiaJeff J Guo, Patricia R Wigle, Kangsan Lammers, et al.
Intractable & Rare Diseases Research|December 8, 2021
Off-label medication use in rare pediatric diseases in the United StatesAlbert Fung, Xiaomeng Yue, Patricia R Wigle, et al.
Research in Social & Administrative Pharmacy : RSAP|January 29, 2011
Evaluation of online consumer medication informationKarissa Y Kim, Anne Metzger, Patricia R Wigle, et al.
International Journal of Cardiology|October 28, 2022
The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year PeriodRawan O Almadfaa, Patricia R Wigle, Ana L Hincapie, et al.
Journal of Managed Care Pharmacy : JMCP|November 12, 2010
ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008Boyang Bian, Christina M L Kelton, Jeff J Guo, et al.
The Journal of Family Practice|January 16, 2010
Answers to your questions about SSRIsChristopher White, Patricia R Wigle, Elizabeth Eichel, et al.
Current Drug Safety|March 10, 2010
Evaluating safety of long-acting beta agonists (LABAs) in patients with asthmaBoyang Bian, Christina M L Kelton, Patricia R Wigle, et al.
Pageof 4